AmpliPhi Biosciences is a biotechnology company engaged in developing, through the application of its proprietary bacteriophage platform, innovative antibacterial solutions for improving human health. The company’s lead product development programs target Gram negative bacterial infections that are often resistant to existing antibiotic treatments. The company is also exploring product development opportunities to combine bacteriophage-based therapeutics with conventional antibiotics to develop multi-target, indication-specific therapeutics. For more information, visit the company’s Web site at www.ampliphibio.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: